Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2014
10/23/2014US20140314874 Pill for enlarging male genital organ
10/23/2014US20140314845 Spherical erythritol granules for direct compression and process of producing same, process of producing tablets by tableting the erythritol granules with a pharmaceutically effective ingredient or nutritional ingredient, and tablets or ordinary candy tablets obtained thereby
10/23/2014US20140314841 Use of Cysteamine and Derivatives Thereof to Suppress Tumor Metastases
10/23/2014US20140314838 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs for treating contrast-induced nephropathy
10/23/2014US20140314835 Sustained release of antiinfectives
10/23/2014US20140314834 Gla monotherapy for use in cancer treatment
10/23/2014US20140314827 Antimicrobial compositions and uses therefor
10/23/2014US20140314794 Compositions and methods for the diagnosis and treatment of tumor
10/23/2014US20140314791 Methods of treating cancer
10/23/2014US20140314785 Compositions and methods for inhibition of the jak pathway
10/23/2014US20140314784 Anti-cxcr4 antibodies and methods of use
10/23/2014US20140314783 Methods for suppressing allergic reactions
10/23/2014US20140314780 Compositions Using Antibodies Directed to GPNMB and Uses Thereof
10/23/2014US20140314776 Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
10/23/2014US20140314774 Her3 antibodies and uses thereof
10/23/2014US20140314773 Compositions and methods for treating alzheimer's disease
10/23/2014US20140314758 Immunogenic tumor associated stromal cell antigen peptides and methods of their use
10/23/2014US20140314757 Phytocannabinoids for use in the treatment of breast cancer
10/23/2014US20140314752 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314751 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314746 Methods for treating or preventing fibrosis in subjects afflicted with scleroderma
10/23/2014US20140314683 Mineral, Nutritional, Cosmetic, Pharmaceutical, And Agricultural Compositions And Methods For Producing The Same
10/23/2014US20140314681 Poly-hapten with topical hormone alopecia hair regrowth system
10/23/2014US20140314676 Methods of treatment with deferiprone
10/23/2014US20140314675 Cancer stem cell isolation
10/23/2014US20140314667 Methods of treating epidermal growth factor deletion mutant viii related disorders
10/23/2014US20140314664 Hydrophobic Molecule-Induced Branched Polymer Aggregates And Their Use
10/21/2014US8865911 Compounds and their use as BACE inhibitors
10/21/2014US8865894 Oxazolidin-2-one compounds and uses thereof
10/21/2014US8865885 MicroRNA fingerprints during human megakaryocytopoiesis
10/21/2014US8865870 Anti-CXCR3 antibodies and methods of use thereof
10/21/2014US8865770 Carbamide peroxide treatments for the reproductive tract
10/21/2014US8865769 Baclofen and acamprosate based therapy of neurological disorders
10/21/2014US8865765 Method for treating eczema
10/21/2014US8865764 Compounds and methods for the treatment of cancer
10/21/2014US8865763 Methods and compositions for altering cell function
10/21/2014US8865755 Dual-acting antihypertensive agents
10/21/2014US8865747 Pioglitazone for use in the treatment of adrenoleukodystrophy
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865728 Combinations comprising methotrexate and DHODH inhibitors
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865718 Heterocyclic inhibitors of glutaminase
10/21/2014US8865715 Substituted 7-(1,2,3-Triazol-4-yl)-pyrrolo[2,3-b]pyrazines
10/21/2014US8865703 Pyridyltriazoles
10/21/2014US8865687 Preparation for the prevention and/or treatment of vascular disorders
10/21/2014US8865679 Use of beta-glucans against biological warfare weapons and pathogens including anthrax
10/21/2014US8865652 Method of treating solid cancers with pegylated IL-10
10/21/2014US8865650 Therapy for complications of diabetes
10/21/2014US8865225 Composition comprising a solid state hypothiocyanite salt of a cation
10/21/2014US8865190 Pharmaceutical compositions for the coordinated delivery of NSAIDs
10/21/2014US8865173 Treatments for pancreatic cancer metastases
10/21/2014US8865139 Topical tetracycline compositions
10/21/2014US8864843 Biomimmetic nanofiber scaffold for soft tissue and soft tissue-to-bone repair, augmentation and replacement
10/16/2014US20140309580 Oxygen therapy with ultrasound
10/16/2014US20140309307 Branched 3-phenylpropionic acid derivatives and their use
10/16/2014US20140309305 Hypertension reducing composition
10/16/2014US20140309303 Nitrated-fatty acids modulation of type ii diabetes
10/16/2014US20140309301 Antiviral treatments
10/16/2014US20140309286 Modulation of tmprss6 expression
10/16/2014US20140309275 Sphingosine Analogs, Compositions, and Methods Related Thereto
10/16/2014US20140309274 Lipidic Furan, Pyrrole, and Thiophene Compounds for Treatment of Cancer, Neurological Disorders, and Fibrotic Disorders
10/16/2014US20140309268 Methods for restoration of histamine balance
10/16/2014US20140309266 Antimicrobial/adjuvant compounds and methods
10/16/2014US20140309259 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309258 Anti-inflammatory compounds
10/16/2014US20140309257 Topoisomerase inhibitors and methods of making and use as therapeutic agents
10/16/2014US20140309254 Pyrrolopyridine derivatives and their use as crth2 antagonists
10/16/2014US20140309252 Compositions and methods for reducing food cravings
10/16/2014US20140309240 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309238 Fluoralkylcarbonyl-oxadiazoles
10/16/2014US20140309233 Syk kinase inhibitors as treatment for malaria
10/16/2014US20140309223 Tyrosine kinase inhibitors
10/16/2014US20140309219 N-substituted oxazinopteridines and oxazinopteridinones
10/16/2014US20140309216 Pharmaceutical compounds
10/16/2014US20140309214 Therapeutical Uses of Eslicarbazepine
10/16/2014US20140309201 Compositions for Providing Vitamin D Year Round and Uses Thereof
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140309189 Highly active nucleoside derivative for the treatment of hcv
10/16/2014US20140309183 Low-Dose Combination Chemotherapy
10/16/2014US20140309180 Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
10/16/2014US20140309179 Treatment of Glaucoma and Other Retinopathies with Gangliosides
10/16/2014US20140309165 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
10/16/2014US20140309164 Deuterated nucleoside prodrugs useful for treating hcv
10/16/2014US20140309159 Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders
10/16/2014US20140308344 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
10/16/2014US20140308342 Reprogramming urokinase into an antibody-recruiting anticancer agent
10/16/2014US20140308331 Interpolymer network delivery system
10/16/2014US20140308305 Yeast-Based Vaccines as Immunotherapy
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/16/2014US20140308282 Pharmaceutical compounds
10/16/2014US20140308281 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates
10/16/2014US20140308274 Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitors
10/16/2014US20140308264 VEGF Analogs and Methods of Use
10/16/2014US20140308260 Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
10/16/2014US20140308251 Intervertebral disc repair, methods and devices therefor
10/16/2014US20140308243 Hepatitis c virus inhibitors
10/16/2014US20140308238 Immunomodulating compositions and methods of use thereof
10/16/2014US20140308212 Edible plant-derived microvesicle compositions for diagnosis and treatment of disease
10/16/2014US20140308201 Antibody drug conjugates
10/14/2014US8862224 Method for treating neovascularization
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 1151